297 related articles for article (PubMed ID: 35396886)
1. Integrated multicomponent analysis based on UHPLC-Q-Exactive Orbitrap-MS and network pharmacology to elucidate the potential mechanism of Baoyuan decoction against idiopathic pulmonary fibrosis.
Zhang B; Gao D; Xu G; Zhu W; Liu J; Sun R; Wang L; Zhang C; Ding Q; Shi Y
Phytochem Anal; 2022 Jul; 33(5):678-695. PubMed ID: 35396886
[TBL] [Abstract][Full Text] [Related]
2. Integrated Network Pharmacology, Molecular Docking and Animal Experiment to Explore the Efficacy and Potential Mechanism of Baiyu Decoction Against Ulcerative Colitis by Enema.
Cui Y; Hu J; Li Y; Au R; Fang Y; Cheng C; Xu F; Li W; Wu Y; Zhu L; Shen H
Drug Des Devel Ther; 2023; 17():3453-3472. PubMed ID: 38024534
[TBL] [Abstract][Full Text] [Related]
3. Research into the anti-pulmonary fibrosis mechanism of Renshen Pingfei formula based on network pharmacology, metabolomics, and verification of AMPK/PPAR-γ pathway of active ingredients.
Yan L; Jiang MY; Fan XS
J Ethnopharmacol; 2023 Dec; 317():116773. PubMed ID: 37308028
[TBL] [Abstract][Full Text] [Related]
4. Bao Yuan decoction alleviates fatigue by restraining inflammation and oxidative stress via the AMPK/CRY2/PER1 signaling pathway.
Zheng Y; Ren X; Qi X; Song R; Zhao C; Ma J; Li X; Deng Q; He Y; Kong L; Qian L; Zhang F; Li M; Sun M; Liu W; Liu H; She G
J Ethnopharmacol; 2024 Jun; 328():118058. PubMed ID: 38513778
[TBL] [Abstract][Full Text] [Related]
5. Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology.
Zhong Y; Hu L; Chen W; Wang B; Sun J; Dong J
BMC Complement Med Ther; 2022 Jun; 22(1):151. PubMed ID: 35672815
[TBL] [Abstract][Full Text] [Related]
6. Schisandrol A, the main active ingredient of Schisandrae Chinensis Fructus, inhibits pulmonary fibrosis through suppression of the TGF-β signaling pathway as revealed by UPLC-Q-TOF/MS, network pharmacology and experimental verification.
Wu Z; Jia M; Zhao W; Huang X; Yang X; Chen D; Qiaolongbatu X; Li X; Wu J; Qian F; Lou Y; Fan G
J Ethnopharmacol; 2022 May; 289():115031. PubMed ID: 35091014
[TBL] [Abstract][Full Text] [Related]
7. Network pharmacology and molecular docking to explore the pharmacological mechanism of Yifei Tongluo granules in treating idiopathic pulmonary fibrosis: A review.
Hou Y; Wang G; Han S; Liu H; Jia X
Medicine (Baltimore); 2023 Jun; 102(22):e33729. PubMed ID: 37266620
[TBL] [Abstract][Full Text] [Related]
8. Explore bioactive ingredients and potential mechanism of Houpo Mahuang decoction for chronic bronchitis based on UHPLC-Q exactive orbitrap HRMS, network pharmacology, and experiment verification.
Gao F; Zhang T; Zhang H; Dai Z; Gu Y; Lu M; Zhang Z; Zeng Q; Shang B; Gao S; Wang N; Xu B; Lei H
J Ethnopharmacol; 2023 Mar; 303():115924. PubMed ID: 36414217
[TBL] [Abstract][Full Text] [Related]
9. The molecular mechanism of Ligusticum wallichii for improving idiopathic pulmonary fibrosis: A network pharmacology and molecular docking study.
Wu X; Li W; Luo Z; Chen Y
Medicine (Baltimore); 2022 Feb; 101(6):e28787. PubMed ID: 35147109
[TBL] [Abstract][Full Text] [Related]
10. Identifying the active compounds and mechanism of action of TongFu XieXia Decoction for treating intestinal obstruction using network pharmacology combined with ultra-high performance liquid chromatography-quadrupole-orbitrap mass spectrometry.
Ma L; Wu Y; Luo J; Li F; Zhang M; Cai Y; Dai Y; Pi Z; Zheng F; Yue H
Rapid Commun Mass Spectrom; 2024 Jan; 38(2):e9664. PubMed ID: 38124169
[TBL] [Abstract][Full Text] [Related]
11. Exploring the efficacy and molecular mechanism of Danhong injection comprehensively in the treatment of idiopathic pulmonary fibrosis by combining meta-analysis, network pharmacology, and molecular docking methods.
Wu X; Li W; Luo Z; Chen Y
Medicine (Baltimore); 2024 May; 103(19):e38133. PubMed ID: 38728523
[TBL] [Abstract][Full Text] [Related]
12. Integrating network pharmacology, experimental validation and molecular docking to reveal the alleviation of Yinhuang granule on idiopathic pulmonary fibrosis.
Wu Z; Shi R; Yan S; Zhang S; Lu B; Huang Z; Ji L
Phytomedicine; 2024 Jun; 128():155368. PubMed ID: 38498951
[TBL] [Abstract][Full Text] [Related]
13. Discovery of the toxicity-related quality markers and mechanisms of Zhi-Zi-Hou-Po decoction based on Chinmedomics combined with differentially absorbed components and network pharmacology.
Wan S; Xie X; Yang G; Feng F
J Ethnopharmacol; 2024 Feb; 320():117408. PubMed ID: 37972910
[TBL] [Abstract][Full Text] [Related]
14. Network pharmacology and experiments in vivo and in vitro reveal that the Jia-Wei-Bu-Shen-Yi-Qi formula (JWBSYQF) and its active ingredient baicalein ameliorate BLM-induced lung fibrosis in mice via PI3K/Akt signaling pathway.
Shi H; Deng L; Zhou Y; Yu H; Huang X; Chen M; Lei Y; Dong J
J Ethnopharmacol; 2023 Oct; 315():116691. PubMed ID: 37247682
[TBL] [Abstract][Full Text] [Related]
15. Ultrahigh-performance liquid chromatography Q-Exactive-Orbitrap mass spectrometry and molecular network analysis alongside network pharmacology to elucidate the active constituents and mechanism of action of Huahong tablet in treating pelvic inflammatory disease.
Li S; Liu Z; Zeng H; Fu J; Sun M; Bao C; Zhang C
Rapid Commun Mass Spectrom; 2024 Jul; 38(14):e9766. PubMed ID: 38747108
[TBL] [Abstract][Full Text] [Related]
16. Systematic characterization of the components and molecular mechanisms of Jinshui Huanxian granules using UPLC-Orbitrap Fusion MS integrated with network pharmacology.
Yuan J; Zhao D; Liu XF; Tian YG; Zhang HJ; Feng SX; Li JS
Sci Rep; 2022 Jul; 12(1):12476. PubMed ID: 35864295
[TBL] [Abstract][Full Text] [Related]
17. Integrated RNA-sequencing and network pharmacology approach reveals the protection of Yiqi Huoxue formula against idiopathic pulmonary fibrosis by interfering with core transcription factors.
Li H; Zhao C; Muhetaer G; Guo L; Yao K; Zhang G; Ji Y; Xing S; Zhou J; Huang X
Phytomedicine; 2022 Sep; 104():154301. PubMed ID: 35792448
[TBL] [Abstract][Full Text] [Related]
18. The cardiac protection of Baoyuan decoction via gut-heart axis metabolic pathway.
Du Z; Wang J; Lu Y; Ma X; Wen R; Lin J; Zhou C; Song Z; Li J; Tu P; Jiang Y
Phytomedicine; 2020 Dec; 79():153322. PubMed ID: 32920286
[TBL] [Abstract][Full Text] [Related]
19. Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology.
Shao D; Liu X; Wu J; Zhang A; Bai Y; Zhao P; Li J
Phytomedicine; 2022 Jul; 102():154177. PubMed ID: 35636171
[TBL] [Abstract][Full Text] [Related]
20. Systems pharmacological study based on UHPLC-Q-Orbitrap-HRMS, network pharmacology and experimental validation to explore the potential mechanisms of Danggui-Shaoyao-San against atherosclerosis.
Bi Y; Han X; Lai Y; Fu Y; Li K; Zhang W; Wang Q; Jiang X; Zhou Y; Liang H; Fan H
J Ethnopharmacol; 2021 Oct; 278():114278. PubMed ID: 34087397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
